Ways Douglas Kirk bought SPRB
July 23, 2025 · Form 4 insider transaction
Ways Douglas Kirk bought 30,000 shares of Spruce Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
30,000
Price
$0.00
Total value
N/A
InsiderWays Douglas Kirk
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJuly 23, 2025
Filing dateJuly 24, 2025
Shares owned after30,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares vest on the first anniversary of the Grant Date, provided that the Option will in any case be fully vested on the date of Company's 2026 annual stockholder meeting, subject to the Reporting Person's Continuous Service (as defined in the 2020 Equity Incentive Plan (the "Plan")) through such vesting date and will vest in full upon a Change in Control (as defined in the Plan).